Health in general is a pillar of the Swiss economy. This is a question of tradition, in particular due to the long-term presence of the pharma industry, and the recent growth in medical device technologies, which build on the valuable collateral of the age-old Swiss tradition of microtechnology. The excellence of Swiss science also contributes to the strength of the market for health-related products and services. According to the think tank “Avenir Suisse”, today about half of the industrial production and services in our economy is related to health.
The concept of “Swiss made” is an important asset for our industries and contributes, day after day, to keeping manufacturing industry in our country, thus avoiding the massive delocalizations that have occurred elsewhere. Such manufacturing is extremely important, not only for industry itself, but also because it enables Switzerland to maintain powerful R&D capabilities and engineering prowess in the country.
This workshop welcomes all those who contribute to the concept of “Swiss made” in health related technologies, to attend speakers which come from industry, science, and specifically from two research centers—CSEM and the Campus Biotech in Geneva—two complimentary organizations that contribute to translating science into innovation.
This event is co-organized by NexTrends and the CSEM and will be held on April 23rd in Universitätspital, Basel